DCAMKL2 Polyclonal Antibody

产品详情

产品名称

DCAMKL2 Polyclonal Antibody

产品货号

YM-A17888

规格

50μL;100μL

种属反应

Human,Mouse

实验应用

WB,IF,ELISA

分子量

83kD

宿主

Rabbit

同种型

IgG

修饰

Unmodified

推荐稀释比

WB 1:500-1:2000;IF 1:200-1:1000;ELISA 1:10000;Not yet tested in other applications.

组成

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

纯化工艺

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

储存

-15°C to -25°C/1 year(Do not lower than -25°C)

浓度

1 mg/ml

克降性

Polyclonal

克隆号

免疫原

The antiserum was produced against synthesized peptide derived from human DCLK2. AA range:1-50

特异性

DCAMKL2 Polyclonal Antibody detects endogenous levels of DCAMKL2 protein.

基因名称

DCLK2

蛋白名称

Serine/threonine-protein kinase DCLK2

别名

DCLK2;DCAMKL2;DCDC3B;DCK2;Serine/threonine-protein kinase DCLK2;CaMK-like CREB regulatory kinase 2;CL2;CLICK-II;CLICK2;Doublecortin domain-containing protein 3B;Doublecortin-like and CAM kinase-like 2;Doublecortin-like kinase 2

基因ID-1

166614

SwissProt

Q8N568

背景

This gene encodes a member of the protein kinase superfamily and the doublecortin family. The protein encoded by this gene contains two N-terminal doublecortin domains, which bind microtubules and regulate microtubule polymerization, a C-terminal serine/threonine protein kinase domain, which shows substantial homology to Ca2+/calmodulin-dependent protein kinase, and a serine/proline-rich domain in between the doublecortin and the protein kinase domains, which mediates multiple protein-protein interactions. The microtubule-polymerizing activity of the encoded protein is independent of its protein kinase activity. Mouse studies show that the DCX gene, another family member, and this gene share function in the establishment of hippocampal organization and that their absence results in a severe epileptic phenotype and lethality, as described in human patients with lissencephaly. Multiple alterna

细胞定位

Cytoplasm, cytoskeleton. Colocalizes with microtubules. .